ClinicalTrials.gov
public full text
Public Domain
Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE
The investigators propose a study to evaluate the safety, local tolerability, convenience, and efficacy of self-administered Icatibant for the treatment of acute attacks of hereditary angioedema. The investigators believe that self administration with Icatibant for treatment of an acute attack of angioedema will not change the time to complete or near complete resolution of symptoms compared to treatment with Icatibant in a medical facility.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- EASSI - Evaluation of the Safety of Self-Administration With Icatibant#831196
- The Neglected Older Adults in Hereditary Angioedema: Insights From the ITACA Registry.#265672
- Single Dose Study of Tulisokibart (MK-7240) in Healthy Chinese Participants (MK-7240-002)#847628
- The Effects of Fractional CO2 Laser on Poikiloderma of Civatte#992875
- Antiangiogenetische Therapie mit Bevacizumab vor Radioembolisation bei hepatisch metastasierten Mammakarzinomen / Kira Isabell Mattern ; Betreuer: Harun Ilhan#661789
Record · ID 887185
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive